Sign up now for ease of access to The Medical Independent, Ireland’s most frequently published medical newspaper, delivering award-winning news and investigative reporting.

  • receive the eCopy two days prior to the printed edition.
  • can partake in our online MCQs.
  • can enter our online sports quiz.


Medicalindependent.ie is Ireland's only investigative medical news website for doctors, healthcare professionals and anyone with an interest in health issues.

Established in 2010, along with its sister publication The Medical Independent, our stated aim is to investigate and analyse the major issues affecting healthcare and the medical profession in Ireland. The Medical Independent has won a number of awards for its investigative journalism, and its stories are frequently picked up by national digital, broadcast and print media. The Medical Independent is published by GreenCross Publishing.

Address: Top Floor, 111 Rathmines Road Lr, Dublin 6

Tel: 353 (01) 441 0024

GreenCross Publishing is owned by Graham Cooke.

Increase in patients on Suboxone in final months of last year

By Mindo - 11th Jan 2021 | 30 views

There was a steady increase in the number of patients being administered buprenorphine/naloxone (Suboxone) in the final months of last year, according to figures provided by the HSE to this newspaper.

A HSE spokesperson told the Medical Independent (MI) that 407 patients
were in receipt of Suboxone in November, compared to 390 in October and 376 in September.

These figures are in line with the steady increase in patients receiving Suboxone during the early period of the pandemic. At the end of May the figure was 340, compared with 262 in February. Suboxone, the brand name for buprenorphine/naloxone, is an alternative substitution treatment for opioid drug dependence.

New regulations were introduced in November 2017 to provide access to certain buprenorphine-based medicinal products (such as Suboxone) in the opioid substitution treatment system on the same statutory basis as methadone.

A survey of measures introduced by the HSE during the early period of the pandemic took place last year.

“The HSE National Social Inclusion Office undertook a survey of the measures put in place in HSE addiction services during March and April in response to the initial outbreak of Covid-19,” the HSE’s spokesperson told MI.

“The results of this survey were to inform future service and resource planning for HSE addiction services. It is not intended to publish the results of the survey in a formal manner.”

At the end of November, 10,974 patients were receiving methadone, according to the HSE spokesperson. In January 2020, the figure was 10,233.

Leave a Reply

Latest
Latest Issue
medical news
The Medical Independent 19th May 2022

You need to be logged in to access this content. Please login or sign up using the links below.

Most Read